Related Experiment Video

Updated: Sep 9, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

650

The Role of Ceramide and Sphingolipid Metabolism in Cancer Therapeutics

Andrea L Cote1,2, Kyla S Jarvis3, Brian M Barth1,3,4

  • 1Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham NH 03824.

Journal of Oncology Research and Therapy
|August 29, 2025
PubMed

Insights

Sphingolipid metabolism, crucial in cancer, involves key lipids like sphingosine-1-phosphate (S1P) and ceramide. Therapies targeting the cancer-promoting S1P/ceramide ratio show promise for cancer treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Sphingolipids are vital bioactive lipids regulating cellular functions, including signaling, membrane composition, and cell fate.
  • Dysregulated sphingolipid metabolism is implicated in cancer development and progression.
  • The balance between sphingosine-1-phosphate (S1P) and ceramide influences cancer cell survival and death.

Purpose of the Study:

  • To review the role of sphingolipid metabolism in cancer.
  • To summarize current and emerging therapeutic strategies targeting sphingolipid metabolism for cancer treatment.

Main Methods:

  • Literature review of studies on sphingolipid metabolism and cancer.
  • Analysis of the roles of key sphingolipids, S1P and ceramide, in cancer cell biology.
  • Examination of therapeutic approaches modulating the ceramide/S1P balance.

Main Results:

  • Cancer cells often exhibit an elevated S1P to ceramide ratio, promoting survival.
  • Ceramide acts as a pro-death lipid, inducing apoptosis, cell cycle arrest, and mitophagy.
  • S1P signaling generally promotes cancer cell survival.

Conclusions:

  • Targeting the sphingolipid metabolism, particularly the ceramide/S1P ratio, is a promising therapeutic strategy in oncology.
  • Both novel therapeutics and repurposed drugs can modulate sphingolipid metabolism for cancer treatment.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.5K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.6K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K